17542 Federal Register / Vol. 80, No. 62 / Wednesday, April 1, 2015 / Notices 

Washington, DC 20423–0001. In 

addition, a copy of each pleading must 

be served on applicant’s representative, 

Roger A. Serpe, General Counsel, 

Indiana Harbor Belt Railroad Company, 

55 W. Monroe Street Suite 1600, 

Chicago, IL 60603. 

Board decisions and notices are 

available on our Web site at 

‘‘WWW.STB.DOT.GOV.’’ 

Decided: March 27, 2015. 

By the Board, Rachel D. Campbell, 

Director, Office of Proceedings. 

Jeffrey Herzig, 

Clearance Clerk. 

[FR Doc. 2015–07560 Filed 3–31–15; 8:45 am] 

BILLING CODE 4915–01–P 

DEPARTMENT OF TRANSPORTATION 

Federal Aviation Administration 

First Meeting: RTCA Special 

Committee 234, Portable Electronic 

Devices (PEDs) 

AGENCY: Federal Aviation 

Administration (FAA), U.S. Department 

of Transportation (DOT). 

ACTION: Meeting notice of RTCA Special 

Committee 234, Portable Electronic 

Devices (PEDs). 

SUMMARY: The FAA is issuing this notice 

to advise the public of the first meeting 

of the RTCA Special Committee 234, 

Portable Electronic Devices (PEDs). 

DATES: The meeting will be held May 

6th to 7th, 2015 from 9:00 a.m.–5:00 

p.m. 

ADDRESSES: RTCA Inc., 1150 18th Street 

NW., Suite 910, Washington, DC 

200036. 

FOR FURTHER INFORMATION CONTACT: The 

RTCA Secretariat, 1150 18th Street NW., 

Suite 910, Washington, DC 20036, or by 

telephone at (202) 330–0652/(202) 833– 

9339, fax at (202) 833–9434, or Web site 

at http://www.rtca.org. Additional 

contact information: RTCA contact is 

Karan Hofmann, khofmann@rtca.org, 

(202) 330–0680. 

SUPPLEMENTARY INFORMATION: Pursuant 

to section 10(a)(2) of the Federal 

Advisory Committee Act (Pub. L. 92– 

463, 5 U.S.C., App.), notice is hereby 

given for a meeting of Special 

Committee 234. The agenda will include 

the following: 

Wednesday May 6th 

• Welcome 

• Administrative Remarks 

• Introductions 

• Agenda Review 

• RTCA Overview Presentation 

• SC–234 Scope and Terms of Reference 

review 

• WG–99 Progress Presentation 

• Presentation on PED ARC Outcome 

• SC–234/WG–99 Structure and 

Organization of Work 

• Proposed Schedule 

• RTCA workspace presentation 

• Other Business 

• Date and Place of Next Meeting 

• Adjourn 

Thursday, May 7th 

• Continuation of Plenary or Working 

Group Session 

Attendance is open to the interested 

public but limited to space availability. 

With the approval of the chairman, 

members of the public may present oral 

statements at the meeting. Persons 

wishing to present statements or obtain 

information should contact the person 

listed in the FOR FURTHER INFORMATION

CONTACT section. Members of the public 

may present a written statement to the 

committee at any time. 

Issued in Washington, DC, on March 27, 

2015. 

Mohannad Dawoud, 

Management Analyst, NextGen, Program 

Oversight and Administration, Federal 

Aviation Administration. 

[FR Doc. 2015–07511 Filed 3–31–15; 8:45 am] 

BILLING CODE 4910–13–P 

DEPARTMENT OF TRANSPORTATION 

Federal Motor Carrier Safety 

Administration 

[Docket No. FMCSA–2014–0216] 

Qualification of Drivers; Exemption 

Applications; Epilepsy and Seizure 

Disorders 

AGENCY: Federal Motor Carrier Safety 

Administration (FMCSA), DOT. 

ACTION: Notice of final disposition. 

SUMMARY: FMCSA announces its 

decision to grant requests from 6 

individuals for exemptions from the 

regulatory requirement that interstate 

commercial motor vehicle (CMV) 

drivers have ‘‘no established medical 

history or clinical diagnosis of epilepsy 

or any other condition which is likely 

to cause loss of consciousness or any 

loss of ability to control a CMV.’’ The 

regulation and the associated advisory 

criteria published in the Code of Federal 

Regulations as the ‘‘Instructions for 

Performing and Recording Physical 

Examinations’’ have resulted in 

numerous drivers being prohibited from 

operating CMVs in interstate commerce 

based on the fact that they have had one 

or more seizures and are taking antiseizure medication, rather than an 

individual analysis of their 

circumstances by a qualified medical 

examiner. The Agency concluded that 

granting exemptions for these CMV 

drivers will provide a level of safety that 

is equivalent to or greater than the level 

of safety maintained without the 

exemptions. FMCSA grants exemptions 

that will allow these 6 individuals to 

operate CMVs in interstate commerce 

for a 2-year period. The exemptions 

preempt State laws and regulations and 

may be renewed. 

DATES: The exemptions are effective 

April 1, 2015. The exemptions expire on 

April 1, 2017. 

FOR FURTHER INFORMATION CONTACT: 

Charles A. Horan, III, Director, Office of 

Carrier, Driver and Vehicle Safety, (202) 

366–4001, fmcsamedical@dot.gov, 

FMCSA, Department of Transportation, 

1200 New Jersey Avenue SE., Room 

W64–224, Washington, DC 20590–0001. 

Office hours are 8:30 a.m. to 5 p.m., e.t., 

Monday through Friday, except Federal 

holidays. 

SUPPLEMENTARY INFORMATION: 

A. Electronic Access 

You may see all the comments online 

through the Federal Document 

Management System (FDMS) at: http:// 

www.regulations.gov. 

Docket: For access to the docket to 

read background documents or 

comments, go to http://

www.regulations.gov and/or Room 

W12–140 on the ground level of the 

West Building, 1200 New Jersey Avenue 

SE., Washington, DC, between 9 a.m. 

and 5 p.m., e.t., Monday through Friday, 

except Federal holidays. 

Privacy Act: In accordance with 5 

U.S.C. 553(c), DOT solicits comments 

from the public to better inform its 

rulemaking process. DOT posts these 

comments, without edit, including any 

personal information the commenter 

provides, to www.regulations.gov, as 

described in the system of records 

notice (DOT/ALL–14 FDMS), which can 

be reviewed at www.dot.gov/privacy. 

B. Background 

Under 49 U.S.C. 31136(e) and 

31315(b), FMCSA may grant an 

exemption from the safety regulations 

for a 2-year period if it finds ‘‘such 

exemption would likely achieve a level 

of safety that is equivalent to or greater 

than the level that would be achieved 

absent such exemption.’’ The statute 

also allows the Agency to renew 

exemptions at the end of the 2-year 

period. 

FMCSA grants 6 individuals an 

exemption from the regulatory 

requirement in§ 391.41(b)(8), to allow 

these individuals who take anti-seizure 

mstockstill on DSK4VPTVN1PROD with NOTICES

Federal Register / Vol. 80, No. 62 / Wednesday, April 1, 2015 / Notices 17543 

1Commercial Driver License Information System 

(CDLIS) is an information system that allows the 

exchange of commercial driver licensing 

information among all the States. CDLIS includes 

the databases of fifty-one licensing jurisdictions and 

the CDLIS Central Site, all connected by a 

telecommunications network. 

2 Motor Carrier Management Information System 

(MCMIS) is an information system that captures 

data from field offices through SAFETYNET, 

CAPRI, and other sources. It is a source for FMCSA 

inspection, crash, compliance review, safety audit, 

and registration data. 

3Engel, J., Fisher, R.S., Krauss, G.L., Krumholz, 

A., and Quigg, M.S., ‘‘Expert Panel 

Recommendations: Seizure Disorders and 

Commercial Motor Vehicle Driver Safety,’’ FMCSA, 

October 15, 2007. 

medication to operate CMVs in 

interstate commerce for a 2-year period. 

The Agency’s decision on these 

exemption applications is based on an 

individualized assessment of each 

applicant’s medical information, 

including the root cause of the 

respective seizure(s), the length of time 

elapsed since the individual’s last 

seizure, and each individual’s treatment 

regimen. In addition, the Agency 

reviewed each applicant’s driving 

record found in the Commercial Driver’s 

License Information System (CDLIS) 1

for commercial driver’s license (CDL) 

holders, and interstate and intrastate 

inspections recorded in Motor Carrier 

Management Information System 

(MCMIS).2 For non-CDL holders, the 

Agency reviewed the driving records 

from the State licensing agency. The 

Agency acknowledges the potential 

consequences of a driver experiencing a 

seizure while operating a CMV. 

However, the Agency believes the 

drivers covered by the exemptions 

granted here have demonstrated that 

they are unlikely to have a seizure and 

their medical condition does not pose a 

risk to public safety. 

In reaching the decision to grant these 

exemption requests, the Agency 

considered both current medical 

literature and information and the 2007 

recommendations of the Agency’s 

Medical Expert Panel (MEP). The 

Agency previously gathered evidence 

for potential changes to the regulation at 

49 CFR 391.41(b)(8) by conducting a 

comprehensive review of scientific 

literature that was compiled into the 

‘‘Evidence Report on Seizure Disorders 

and Commercial Vehicle Driving’’ 

(Evidence Report) [CD–ROM HD 

TL230.3 .E95 2007]. The Agency then 

convened a panel of medical experts in 

the field of neurology (the MEP) on May 

14–15, 2007, to review 49 CFR 

391.41(b)(8) and the advisory criteria 

regarding individuals who have 

experienced a seizure, and the 2007 

Evidence Report. The Evidence Report 

and the MEP recommendations are 

published on-line at http://

www.fmcsa.dot.gov/rules-regulations/

topics/mep/mep-reports.htm, under 

Seizure Disorders, and are in the docket 

for this notice. 

MEP Criteria for Evaluation 

On October 15, 2007, the MEP issued 

the following recommended criteria for 

evaluating whether an individual with 

epilepsy or a seizure disorder should be 

allowed to operate a CMV.3 The MEP 

recommendations are included in 

previously published dockets. 

Epilepsy diagnosis. If there is an 

epilepsy diagnosis, the applicant should 

be seizure-free for 8 years, on or off 

medication. If the individual is taking 

anti-seizure medication(s), the plan for 

medication should be stable for 2 years. 

Stable means no changes in medication, 

dosage, or frequency of medication 

administration. Recertification for 

drivers with an epilepsy diagnosis 

should be performed every year. 

Single unprovoked seizure. If there is 

a single unprovoked seizure (i.e., there 

is no known trigger for the seizure), the 

individual should be seizure-free for 4 

years, on or off medication. If the 

individual is taking anti-seizure 

medication(s), the plan for medication 

should be stable for 2 years. Stable 

means no changes in medication, 

dosage, or frequency of medication 

administration. Recertification for 

drivers with a single unprovoked 

seizure should be performed every 2 

years. 

Single provoked seizure. If there is a 

single provoked seizure (i.e., there is a 

known reason for the seizure), the 

Agency should consider specific criteria 

that fall into the following two 

categories: low-risk factors for 

recurrence and moderate-to-high risk 

factors for recurrence. 

• Examples of low-risk factors for 

recurrence include seizures that were 

caused by a medication; by nonpenetrating head injury with loss of 

consciousness less than or equal to 30 

minutes; by a brief loss of consciousness 

not likely to recur while driving; by 

metabolic derangement not likely to 

recur; and by alcohol or illicit drug 

withdrawal. 

• Examples of moderate-to-high-risk 

factors for recurrence include seizures 

caused by non-penetrating head injury 

with loss of consciousness or amnesia 

greater than 30 minutes, or penetrating 

head injury; intracerebral hemorrhage 

associated with a stroke or trauma; 

infections; intracranial hemorrhage; 

post-operative complications from brain 

surgery with significant brain 

hemorrhage; brain tumor; or stroke. 

The MEP report indicates individuals 

with moderate to high-risk conditions 

should not be certified. Drivers with a 

history of a single provoked seizure 

with low risk factors for recurrence 

should be recertified every year. 

Medical Review Board 

Recommendations and Agency Decision 

FMCSA presented the MEP’s findings 

and the Evidence Report to the Medical 

Review Board (MRB) for consideration. 

The MRB reviewed and considered the 

2007 ‘‘Seizure Disorders and 

Commercial Driver Safety’’ evidence 

report and the 2007 MEP 

recommendations. The MRB 

recommended maintaining the current 

advisory criteria, which provide that 

‘‘drivers with a history of epilepsy/

seizures off anti-seizure medication and 

seizure-free for 10 years may be 

qualified to drive a CMV in interstate 

commerce. Interstate drivers with a 

history of a single unprovoked seizure 

may be qualified to drive a CMV in 

interstate commerce if seizure-free and 

off anti-seizure medication for a 5 year 

period or more’’ [Advisory criteria to 49 

CFR 391.43(f)]. 

The Agency acknowledges the MRB’s 

position on the issue but believes 

relevant current medical evidence 

supports a less conservative approach. 

The medical advisory criteria for 

epilepsy and other seizure or loss of 

consciousness episodes was based on 

the 1988 ‘‘Conference on Neurological 

Disorders and Commercial Drivers’’ 

(NITS Accession No. PB89–158950/AS). 

A copy of the report can be found in the 

docket referenced in this notice. 

The MRB’s recommendation treats all 

drivers who have experienced a seizure 

the same, regardless of individual 

medical conditions and circumstances. 

In addition, the recommendation to 

continue prohibiting drivers who are 

taking anti-seizure medication from 

operating a CMV in interstate commerce 

does not consider a driver’s actual 

seizure history and time since the last 

seizure. The Agency has decided to use 

the 2007 MEP recommendations as the 

basis for evaluating applications for an 

exemption from the seizure regulation 

on an individual, case-by-case basis. 

C. Exemptions 

Following individualized assessments 

of the exemption applications, 

including a review of detailed follow-up 

information requested from each 

applicant, FMCSA is granting 

exemptions from 49 CFR 391.41(b)(8) to 

6 individuals. Under current FMCSA 

regulations, all of the 6 drivers receiving 

mstockstill on DSK4VPTVN1PROD with NOTICES

17544 Federal Register / Vol. 80, No. 62 / Wednesday, April 1, 2015 / Notices 

exemptions from 49 CFR 391.41(b)(8) 

would have been considered physically 

qualified to drive a CMV in interstate 

commerce except that they presently 

take or have recently stopped taking 

anti-seizure medication. For these 6 

drivers, the primary obstacle to medical 

qualification was the FMCSA Advisory 

Criteria for Medical Examiners, based 

on the 1988 ‘‘Conference on 

Neurological Disorders and Commercial 

Drivers,’’ stating that a driver should be 

off anti-seizure medication in order to 

drive in interstate commerce. In fact, the 

Advisory Criteria have little if anything 

to do with the actual risk of a seizure 

and more to do with assumptions about 

individuals who are taking anti-seizure 

medication. 

In addition to evaluating the medical 

status of each applicant, FMCSA 

evaluated the crash and violation data 

for the 6 drivers, some of whom 

currently drive a CMV in intrastate 

commerce. The CDLIS and MCMIS were 

searched for crash and violation data on 

the 6 applicants. For non-CDL holders, 

the Agency reviewed the driving records 

from the State licensing agency. 

These exemptions are contingent on 

the driver maintaining a stable 

treatment regimen and remaining 

seizure-free during the 2-year exemption 

period. The exempted drivers must 

submit annual reports from their 

treating physicians attesting to the 

stability of treatment and that the driver 

has remained seizure-free. The driver 

must undergo an annual medical 

examination by a medical examiner, as 

defined by 49 CFR 390.5, following the 

FCMSA’s regulations for the physical 

qualifications for CMV drivers. 

FMCSA published a notice of receipt 

of application and requested public 

comment during a 30-day public 

comment period in a Federal Register 

notice for each of the applicants. A short 

summary of the applicants’ 

qualifications and a discussion of the 

comments received, if any, follows this 

section. For applicants who were denied 

an exemption, a notice will be 

published at a later date. 

D. Comments 

Docket # FMCSA–2014–0216 

On October 1, 2014, FMCSA 

published a notice of receipt of 

exemption applications and requested 

public comment on seven individuals 

(79 FR 59345; Docket number FMCSA– 

2014–23439). The comment period 

ended on October 31, 2014. No 

commenters responded to this Federal 

Register notice. Of the seven applicants, 

one was denied. The Agency has 

determined that the following six 

applicants should be granted an 

exemption. 

Ronald J. Bland 

Mr. Bland is a 51 year-old class A 

CDL holder in Ohio. He has a history of 

three possible seizures due to head 

trauma in 2003. He has taken antiseizure medication since 2004 with the 

dosage and frequency remaining the 

same since 2009. If granted an 

exemption, he would like to drive a 

CMV. His physician states he is 

supportive of Mr. Bland receiving an 

exemption. 

Joseph M. Celedonia 

Mr. Celedonia is a 44 year-old driver 

in Maryland. He has a history of 

seizures and has remained seizure free 

since 1999. He takes anti-seizure 

medication with the dosage and 

frequency remaining the same since 

2007. If granted an exemption, he would 

like to drive a CMV. His physician states 

he is supportive of Mr. Celedonia 

receiving an exemption. 

Mathew J. Chizek 

Mr. Chizek is a 35 year-old driver in 

Wisconsin. He has a history of seizures 

and has remained seizure free since 

2004. He takes anti-seizure medication 

with the dosage and frequency 

remaining the same since 2008. If 

granted the exemption, he would like to 

drive a CMV. His physician states he is 

supportive of Mr. Chizek receiving an 

exemption. 

Gregory B. Hardy 

Mr. Hardy is a 54 year-old class B 

CDL holder in Massachusetts. He has a 

history of seizure and has remained 

seizure free since 1985. He takes antiseizure medication with the dosage and 

frequency remaining the same since 

2011. If granted the exemption, he 

would like to drive a CMV. His 

physician states that he is supportive of 

Mr. Hardy receiving an exemption. 

Thomas K. Mitchell 

Mr. Mitchell is a 54 year-old class A 

CDL holder in Mississippi. He has a 

history of seizures and has remained 

seizure free since 1999. He takes antiseizure medication with the dosage and 

frequency remaining the same since that 

time. If granted the exemption, he 

would like to drive a CMV. His 

physician states that he is supportive of 

Mr. Mitchell receiving an exemption. 

Himat S. Sandhu 

Mr. Sandhu is a 52 year-old driver in 

California. He has a history of a possible 

seizure after a surgical resection of an 

arteriovenous malformation. He does 

not require anti-seizure medication. His 

physician states that he is supportive of 

Mr. Sandhu receiving an exemption. 

E. Basis for Exemption 

Under 49 U.S.C. 31136(e) and 

31315(b), FMCSA may grant an 

exemption from the epilepsy/seizure 

standard in 49 CFR 391.41(b)(8) if the 

exemption is likely to achieve an 

equivalent or greater level of safety than 

would be achieved without the 

exemption. Without the exemption, 

applicants will continue to be restricted 

to intrastate driving. With the 

exemption, applicants can drive in 

interstate commerce. Thus, the Agency’s 

analysis focuses on whether an equal or 

greater level of safety is likely to be 

achieved by permitting each of these 

drivers to drive in interstate commerce 

as opposed to restricting the driver to 

driving in intrastate commerce. 

Conclusion 

The Agency is granting exemptions 

from the epilepsy standard, 49 CFR 

391.41(b)(8), to 6 individuals based on 

a thorough evaluation of each driver’s 

safety experience, and medical 

condition. Safety analysis of 

information relating to these 6 

applicants meets the burden of showing 

that granting the exemptions would 

achieve a level of safety that is 

equivalent to or greater than the level 

that would be achieved without the 

exemption. By granting the exemptions, 

the interstate CMV industry will gain 6 

highly trained and experienced drivers. 

In accordance with 49 U.S.C. 

31315(b)(1), each exemption will be 

valid for 2 years, with annual 

recertification required unless revoked 

earlier by FMCSA. The exemption will 

be revoked if the following occurs: (1) 

The person fails to comply with the 

terms and conditions of the exemption; 

(2) the exemption has resulted in a 

lower level of safety than was 

maintained prior to being granted; or (3) 

continuation of the exemption would 

not be consistent with the goals and 

objectives of 49 U.S.C. 31136 and 31315. 

FMCSA exempts the following 6 

drivers for a period of 2 years with 

annual medical certification required: 

Ronald Bland (OH); Joseph Celedonia 

(MD); Mathew Chizek (WI); Gregory 

Hardy (MA); Thomas Mitchell (MS); and 

Himat Sandhu (CA) from the 

prohibition of CMV operations by 

persons with a clinical diagnosis of 

epilepsy or seizures. If the exemption is 

still in effect at the end of the 2-year 

period, the person may apply to FMCSA 

for a renewal under procedures in effect 

at that time. 

mstockstill on DSK4VPTVN1PROD with NOTICES

Federal Register / Vol. 80, No. 62 / Wednesday, April 1, 2015 / Notices 17545 

Issued on: March 19, 2015. 

Larry W. Minor, 

Associate Administrator for Policy. 

[FR Doc. 2015–07351 Filed 3–31–15; 8:45 am] 

BILLING CODE 4910–EX–P 

DEPARTMENT OF TRANSPORTATION 

Federal Aviation Administration 

Agency Information Collection 

Activities: Requests for Comments; 

Clearance of Renewed Approval of 

Information Collection: Flightcrew 

Member Duty and Rest Requirements 

AGENCY: Federal Aviation 

Administration (FAA), DOT. 

ACTION: Notice and request for 

comments. 

SUMMARY: In accordance with the 

Paperwork Reduction Act of 1995, FAA 

invites public comments about our 

intention to request the Office of 

Management and Budget (OMB) 

approval to renew an information 

collection. The Federal Register Notice 

with a 60-day comment period soliciting 

comments on the following collection of 

information was published on December 

22, 2014 (79 FR 76435). Reporting and 

recordkeeping are required any time a 

certificated air carrier has exceeded a 

maximum daily flight time limit or a 

maximum daily Flight Duty Period 

(FDP) limit. It is also required for the 

voluntary development of a Fatigue Risk 

Management System (FRMS), and for 

fatigue training. 

DATES: Written comments should be 

submitted by May 1, 2015. 

ADDRESSES: Interested persons are 

invited to submit written comments on 

the proposed information collection to 

the Office of Information and Regulatory 

Affairs, Office of Management and 

Budget. Comments should be addressed 

to the attention of the Desk Officer, 

Department of Transportation/FAA, and 

sent via electronic mail to 

oira_submission@omb.eop.gov, or faxed 

to (202) 395–6974, or mailed to the 

Office of Information and Regulatory 

Affairs, Office of Management and 

Budget, Docket Library, Room 10102, 

725 17th Street NW., Washington, DC 

20503. 

Public Comments Invited: You are 

asked to comment on any aspect of this 

information collection, including (a) 

Whether the proposed collection of 

information is necessary for FAA’s 

performance; (b) the accuracy of the 

estimated burden; (c) ways for FAA to 

enhance the quality, utility and clarity 

of the information collection; and (d) 

ways that the burden could be 

minimized without reducing the quality 

of the collected information. The agency 

will summarize and/or include your 

comments in the request for OMB’s 

clearance of this information collection. 

FOR FURTHER INFORMATION CONTACT: 

Ronda Thompson at (202) 267–1416, or 

by email at: Ronda.Thompson@faa.gov. 

SUPPLEMENTARY INFORMATION: 

OMB Control Number: 2120–0751. 

Title: Flightcrew Member Duty and 

Rest Requirements. 

Form Numbers: There are no FAA 

forms associated with this collection. 

Type of Review: Extension without 

change of an information collection. 

Background: The FAA collects reports 

from air carriers certificated under 14 

CFR part 121 as prescribed in 14 CFR 

part 117, 117.11 and 117.19 of the 

Flightcrew Member Duty and Rest 

Requirements, to notify the FAA that 

the certificate holder has extended a 

flight time and/or FDP limitation. 

Additionally, if air carriers choose to 

develop a Fatigue Risk Management 

System (FRMS) they are required to 

collect data specific to the need of the 

operation for which they will seek an 

FRMS authorization. Each air carrier is 

required to develop specific elements 

and incorporate these elements into 

their training program and submit the 

revised training program for approval. 

Respondents: 67 certificated air 

carriers. 

Frequency: Information is collected 

on occasion. 

Estimated Average Burden per 

Response: 20 hours. 

Estimated Total Annual Burden: 

3,178 hours. 

Issued in Washington, DC, on March 27, 

2015. 

Albert R. Spence, 

FAA Assistant Information Collection 

Clearance Officer, IT Enterprises Business 

Services Division, ASP–110. 

[FR Doc. 2015–07513 Filed 3–31–15; 8:45 am] 

BILLING CODE 4910–13–P 

DEPARTMENT OF TREASURY 

Internal Revenue Service 

Information Reporting Program 

Advisory Committee (IRPAC); 

Nominations 

AGENCY: Internal Revenue Service, 

Department of Treasury. 

ACTION: Request for nominations. 

SUMMARY: The Internal Revenue Service 

(IRS) requests nominations of 

individuals for selection to the 

Information Reporting Program 

Advisory Committee (IRPAC). 

Nominations should describe and 

document the proposed member’s 

qualifications for IRPAC membership, 

including the applicant’s past or current 

affiliations and dealings with the 

particular tax segment or segments of 

the community that he or she wishes to 

represent on the committee. In addition 

to individual nominations, the IRS is 

soliciting nominations from professional 

and public interest groups that wish to 

have representatives on the IRPAC. 

IRPAC will be comprised of 19 

members. There are six positions open 

for calendar year 2016. It is important 

that IRPAC continue to represent a 

diverse taxpayer and stakeholder base. 

Accordingly, to maintain membership 

diversity, selection is based on the 

applicant’s qualifications as well as the 

taxpayer or stakeholder base he/she 

represents. 

The IRPAC advises the IRS on 

information reporting issues of mutual 

concern to the private sector and the 

federal government. The committee 

works with the Commissioner of 

Internal Revenue and other IRS 

leadership to provide recommendations 

on a wide range of information reporting 

administration issues. Membership is 

balanced to include representation from 

the tax professional community, small 

and large businesses, banks, colleges 

and universities, and industries such as 

securities, payroll, finance and software. 

DATES: Written nominations must be 

received on or before May 29, 2015. 

ADDRESSES: Nominations should be sent 

to: Ms. Caryl Grant, IRS National Public 

Liaison, CL:NPL:SRM, Room 7559, 1111 

Constitution Avenue NW., Washington, 

DC 20224, Attn: IRPAC Nominations. 

Applications may also be submitted via 

fax to 855–811–8020 or via email at 

PublicLiaison@irs.gov. Application 

packages are available on the IRS Web 

site at http://www.irs.gov/TaxProfessionals . Application packages 

may also be requested by telephone 

from National Public Liaison, 202–317– 

6851 (not a toll-free number). 

FOR FURTHER INFORMATION CONTACT: Ms. 

Caryl Grant at 202–317–6851 (not a tollfree number) or PublicLiaison@irs.gov. 

SUPPLEMENTARY INFORMATION: 

Established in 1991 in response to an 

administrative recommendation in the 

final Conference Report of the Omnibus 

Budget Reconciliation Act of 1989, the 

IRPAC works closely with the IRS to 

provide recommendations on a wide 

range of issues intended to improve the 

information reporting program and 

achieve fairness to taxpayers. Conveying 

the public’s perception of IRS activities 

to the Commissioner, the IRPAC is 

comprised of individuals who bring 

mstockstill on DSK4VPTVN1PROD with NOTICES